Sarepta Therapeutics Outlines 2026 Priorities on Strong Cash Position NAVI Q1 2026 Earnings EPS Surges Past Estimates on Strong Operating Performance April Jobs Report Preview Labor Market Cooling Yet Resilient Economists Expect